Serum apoB levels independently predict the development of non‐alcoholic fatty liver disease: A 7‐year prospective study

Abstract Background & Aims Cross‐sectional studies have shown that apolipoprotein B (apoB) is positively associated with the prevalence of non‐alcoholic fatty liver disease ( NAFLD ). This study aimed to investigate the prospective relationship between the serum apoB levels and the development of NAFLD in a Chinese population. Methods A cohort of 7077 initially NAFLD ‐free participants was enrolled in this prospectively study. The incidence of NAFLD was calculated among participants with different baseline serum apoB quintiles. Cox proportional hazards regression analyses were conducted to calculate the risks for incident NAFLD . Results During 41 555 person‐year follow‐ups, 1139 incident NAFLD cases were identified. The baseline apoB levels were linear and positively correlated with NAFLD incidence. The incidence was 16.99, 22.63, 24.73, 37.51 and 42.77 per 1000 person‐year follow‐up for participants with baseline apoB levels in quintiles 1–5, respectively. Compared with participants with baseline apoB levels in quintile 1, the hazard ratios (95% confidence interval) for incident NAFLD were 1.353 (1.100–1.663), 1.482 (1.207–1.820), 2.232 (1.832–2.720) and 2.543 (2.082–3.106) for participants with baseline apoB levels in quintile 2–5, respectively. The hazard ratios were attenuated but remained statistically significant after adjusting for age, gender, body mass index and variables associated with metabolic syndrome. Conclusion Elevated serum apoB levels independently predict an increased risk for incident NAFLD .